Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations

BACKGROUND: Standard chemotherapy with taxanes, such as paclitaxel (PTX), remains the mainstay of systemic treatment of triple-negative breast cancer. Nanotechnology-based formulations have gradually replaced PTX injection and are widely used in China. However, no studies have compared the colloidal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jun, Li, Renjie, Yang, Yanfang, Dong, Wujun, Wang, Yujie, Wang, Hongliang, Sun, Tong, Li, Lin, Shen, Qiqi, Qin, Caiyun, Xu, Xiaoyan, Liao, Hengfeng, Jin, Yiqun, Xia, Xuejun, Liu, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256566/
https://www.ncbi.nlm.nih.gov/pubmed/34225762
http://dx.doi.org/10.1186/s12951-021-00946-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256566/
https://www.ncbi.nlm.nih.gov/pubmed/34225762
http://dx.doi.org/10.1186/s12951-021-00946-w

Ejemplares similares